Search results
Cetera Trust Company N.A Makes New $108,000 Investment in QuidelOrtho Co. (NASDAQ:QDEL)
ETF DAILY NEWS· 9 hours ago(NASDAQ:QDEL – Free Report) in the 4th quarter, HoldingsChannel reports. The fund acquired 1,460 shares of the company’s stock, valued at approximately $108,000. Other hedge funds and other ...
An arthritis drug helps old dogs, but some owners worry about side effects
Washington Post via Yahoo News· 3 days agoAround the country, veterinarians are prescribing a breakthrough new arthritis drug for dogs -...
72-year-old patient had COVID for record 613 days, accumulated over 50 mutations from virus before...
New York Post· 4 days agoThe most extended case of COVID-19 ever recorded before this was from a British man who suffered...
Novartis Kesimpta® six-year efficacy data show substantial benefits in recently diagnosed...
CBS 47 Fresno· 6 days agoContinuous Kesimpta® treatment for up to six years showed sustained efficacy in recently diagnosed (≤3 years) treatment-naïve people living with relapsing multiple sclerosis (RMS) in an analysis ...
New Agent Shows Early Promise in Triple-Class Refractory MM
Medscape· 6 days agoWith linvoseltamab and other bispecific antibodies inducing deep and durable responses, there might...
PFAS chemical levels prompt Kalispell to issue drinking water notice
KPAX Missoula· 5 days agoTesting revealed that one of Kalispell's Public Water System wells has PFAS higher than the newly established limits set by the EPA.
Scientists in Missouri, Virginia receive pediatric heart transplantation research grants
NewMediaWire via Yahoo Finance· 1 day agoDALLAS, April 22, 2024 — Scientific researchers in Missouri and Virginia have been awarded nearly...
Checkpoint Inhibitors: A New Hope for Cancer Treatment
Forbes· 6 days agoThis article is part of an ongoing series on checkpoint inhibitors, a novel cancer immunotherapy....
TG Therapeutics Awarded National Contract by the Department of Veterans Affairs for BRIUMVI as the...
Morningstar· 5 days agoThe contract period includes the base year ordering period of June 17, 2024 to June 16, 2025, as well as four one-year option periods that may be exercised unilaterally by the...
Immunovia announces updated financial calendar
WDTN-TV 2 Dayton· 1 day agoImmunovia (NASDAQ Stockholm: IMMNOV), the diagnostics company with the mission to increase pancreatic cancer survival rates through early detection, updates its financial calendar for 2024.
